title: Comment on GnRH analogue cotreatment with chemotherapy for preservation of ovarian function.
authors.forename: Eva
authors.initials: E
authors.lastname: Balkenende
authors.forename: Taghride
authors.initials: T
authors.lastname: Dahhan
authors.forename: Fulco
authors.initials: F
authors.lastname: van der Veen
authors.forename: Mariëtte
authors.initials: M
authors.lastname: Goddijn
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D011247:Pregnancy; D016649:Primary Ovarian Insufficiency / Q000139:chemically induced* / Q000517:prevention & control*
chemical_list: D000970:Antineoplastic Agents; D007987:Gonadotropin-Releasing Hormone